Scarica l'app Stockscreener
70.69
3.00%
2.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$68.63
Aprire:
$69.07
Volume 24 ore:
1.33M
Relative Volume:
0.33
Capitalizzazione di mercato:
$34.92B
Reddito:
$198.10B
Utile/perdita netta:
$-6.45B
Rapporto P/E:
-5.378
EPS:
-13.1443
Flusso di cassa netto:
$7.11B
1 W Prestazione:
+2.66%
1M Prestazione:
+8.57%
6M Prestazione:
+84.52%
1 anno Prestazione:
+98.51%
Intervallo 1D:
$68.90
$70.97
Intervallo di 1 settimana:
$67.55
$71.21
Portata 52W:
$31.63
$71.21
Centene Corp Stock (CNC) Company Profile
Nome
Centene Corp
Settore
Industria
Telefono
(314) 725-4477
Indirizzo
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, ELV, CI, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
70.69 | 34.92B | 198.10B | -6.45B | 7.11B | -13.14 |
UNH
Unitedhealth Group Inc
|
421.31 | 378.16B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
94.35 | 120.67B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
438.85 | 95.17B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
305.49 | 80.72B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
428.82 | 51.49B | 137.20B | 1.15B | 1.27B | 9.3439 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-08-11 | Aggiornamento | Argus | Hold → Buy |
| 2026-06-23 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2026-05-20 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-04-29 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2026-04-29 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-10-14 | Iniziato | Goldman | Sell |
| 2025-07-28 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-07-16 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Downgrade | UBS | Buy → Neutral |
| 2025-06-09 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-02 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Aggiornamento | Jefferies | Underperform → Hold |
| 2025-02-06 | Downgrade | Argus | Buy → Hold |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-12-13 | Aggiornamento | UBS | Neutral → Buy |
| 2024-12-10 | Downgrade | Jefferies | Hold → Underperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-03-21 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2024-01-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Iniziato | UBS | Neutral |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Iniziato | Argus | Buy |
| 2022-08-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Ripresa | Barclays | Overweight |
| 2022-07-14 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-06-21 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Ripresa | Bernstein | Outperform |
| 2022-05-26 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-01-07 | Ripresa | Barclays | Overweight |
| 2022-01-06 | Ripresa | JP Morgan | Overweight |
| 2021-12-14 | Iniziato | Goldman | Neutral |
| 2021-12-13 | Reiterato | BMO Capital Markets | Outperform |
| 2021-12-13 | Reiterato | BofA Securities | Buy |
| 2021-12-13 | Reiterato | Credit Suisse | Neutral |
| 2021-12-13 | Reiterato | Mizuho | Neutral |
| 2021-12-13 | Reiterato | Oppenheimer | Outperform |
| 2021-12-13 | Reiterato | Stephens | Overweight |
| 2021-12-13 | Reiterato | Truist | Buy |
| 2021-12-13 | Reiterato | Wells Fargo | Overweight |
| 2021-12-13 | Reiterato | Wolfe Research | Outperform |
| 2021-11-01 | Downgrade | Citigroup | Buy → Neutral |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-07-09 | Iniziato | Seaport Global Securities | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Overweight |
| 2021-05-11 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Iniziato | Mizuho | Neutral |
| 2021-01-21 | Ripresa | Goldman | Neutral |
| 2021-01-15 | Downgrade | Jefferies | Buy → Hold |
| 2020-09-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Iniziato | SVB Leerink | Outperform |
| 2020-02-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Ripresa | Evercore ISI | Outperform |
| 2020-01-28 | Reiterato | Bernstein | Outperform |
| 2020-01-06 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-05-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-14 | Iniziato | Stephens | Overweight |
| 2018-10-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Ripresa | Citigroup | Neutral |
| 2017-12-18 | Reiterato | Jefferies | Buy |
| 2017-09-13 | Reiterato | Leerink Partners | Mkt Perform |
| 2017-06-07 | Iniziato | Morgan Stanley | Overweight |
| 2017-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Iniziato | Deutsche Bank | Buy |
| 2017-03-23 | Downgrade | Citigroup | Buy → Neutral |
| 2017-02-08 | Reiterato | Barclays | Overweight |
| 2017-02-07 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Centene Corp Borsa (CNC) Ultime notizie
UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy? - Zacks Investment Research
Centene Corporation Demonstrates Commitment to CHOICE Arrangements through Benefit Programs in Indiana, Ohio and Oklahoma - PR Newswire
At $70.16 each, 7,130 Centene (CNC) shares were withheld for executive Carson's taxes. - Stock Titan
Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth? - Zacks Investment Research
Centene: The Turnaround Has More Room To Run (NYSE:CNC) - Seeking Alpha
Centene Remains A Buy Heading Into Q3 (NYSE:CNC) - Seeking Alpha
Centene Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Centene unveils national provider gold card program - Fierce Healthcare
Centene's Gold Card Push Could Ease CostsBut Will Savings Follow? - Zacks Investment Research
Centene's Gold Card Push Could Ease CostsBut Will Savings Follow? - TradingView
Centene joins insurers waiving prior authorizations for top providers - Healthcare Dive
Centene Sued Over a Dead Patient — And the Problems Run Far Deeper Than One Lawsuit - https://www.lawnews.co.uk/
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene (CNC) Stock Trades Up, Here Is Why - Yahoo Finance
Centene to launch prior authorization gold card program - Modern Healthcare
Centene Corporation (CNC) Stock Forecasts - Yahoo Finance
Centene to Launch Nationwide Gold Card Program for Qualifying Providers - TradingView
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene vs. Molina: Which Managed Care Stock Has More Upside? - Zacks Investment Research
How Evidence Can Guide Prevention Investments - Centene Corporation
Centene vs. Molina: Which Managed Care Stock Has More Upside? - Yahoo Finance
Centene vs. Molina: Which Managed Care Stock Has More Upside? - Zacks Investment Research
Form 4 Centene Corp For: 11 October By Investing.com - Investing.com India
Centene Q3 2026 Preview: The Quarter Is Easy, The 2027 Bridge Is Not (NYSE:CNC) - Seeking Alpha
Centene Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Humana rebounds, Aetna slips: Winners and losers in the 2027 MA star ratings - Fierce Healthcare
Cantor Fitzgerald reiterates Centene stock Overweight rating at $75 - Investing.com
ACA plan provider takes the top spot on the managed care list - The Business Journals
Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits? - Zacks Investment Research
Centene Corp To Redeem $568.66 Mln Of 4.25% Notes Due 2027 On Oct 23, 2026 - TradingView
NH Healthy Families Earns a 4.0 out of 5-Star NCQA Medicaid Health Plan Rating - Centene Corporation
Centene to redeem $568.7M of 4.25% notes due 2027 on Oct. 23 - TradingView
Earnings Preview: What to Expect From Centene's Report - Barchart.com
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Zacks Investment Research
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - Yahoo Finance
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy? - TradingView
Centene to Offer Expanded Health Access to Eligible Ambetter Members - www.marketscreener.com
Ambetter Health Solutions and Marathon Health Expand Access to Primary Care for Members in Indiana and Missouri - PR Newswire
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated - Zacks Investment Research
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated - Yahoo Finance
Buy 5 Growth Stocks to Boost Your Portfolio in Q4 After a Mixed Q3 - Zacks Investment Research
Centene Corp (XBUL:QEN) Stock Price, Trades & News - GuruFocus
Oscar Health Trading at a Premium: Why Should You Still Buy It? - Zacks Investment Research
Centene Corp. stock gains 1.11 percent ahead of Q3 results - AD HOC NEWS
Centene reaffirms 2026 earnings guidance: Centene stock gains 1.68 percent - AD HOC NEWS
Are Investors Undervaluing Centene (CNC) Right Now? - Zacks Investment Research
Are Investors Undervaluing Centene (CNC) Right Now? - Yahoo Finance UK
Are Investors Undervaluing Centene (CNC) Right Now? - Yahoo Finance
Centene Corp (CNC) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Centene Corp Azioni (CNC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Centene Corp Azioni (CNC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KOSTER CHRISTOPHER | Officer |
Aug 26 '26 |
Proposed Sale |
66.90 |
56,500 |
3,779,852 |
0 |
| Burdick Kenneth A | Former Director |
Aug 26 '26 |
Proposed Sale |
65.00 |
43,600 |
2,834,000 |
0 |
| KOSTER CHRISTOPHER | Secretary & General Counsel |
Aug 18 '26 |
Sale |
65.36 |
47,603 |
3,111,332 |
305,354 |
| KOSTER CHRISTOPHER | Officer |
Aug 18 '26 |
Proposed Sale |
65.36 |
47,603 |
3,111,262 |
0 |
| Burdick Kenneth A | Former Director |
Aug 05 '26 |
Proposed Sale |
68.15 |
100,000 |
6,815,182 |
0 |
| Burdick Kenneth A | Director |
Jun 10 '26 |
Proposed Sale |
64.55 |
80,000 |
5,164,227 |
0 |
| Burdick Kenneth A | Director |
Jun 10 '26 |
Sale |
64.55 |
80,000 |
5,164,000 |
197,086 |
| Burdick Kenneth A | Director |
Dec 04 '25 |
Sale |
39.00 |
32,796 |
1,279,044 |
272,365 |
| Burdick Kenneth A | Director |
Dec 04 '25 |
Proposed Sale |
39.00 |
32,796 |
1,279,044 |
0 |
| Burdick Kenneth A | Director |
Dec 03 '25 |
Sale |
39.04 |
33,211 |
1,296,557 |
305,161 |
3.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):